Your browser is no longer supported. Please, upgrade your browser.
GSK GlaxoSmithKline plc monthly Stock Chart
GlaxoSmithKline plc
Index- P/E19.76 EPS (ttm)2.06 Insider Own0.20% Shs Outstand2.52B Perf Week1.02%
Market Cap102.22B Forward P/E13.62 EPS next Y2.98 Insider Trans0.00% Shs Float2.47B Perf Month1.12%
Income5.12B PEG2.22 EPS next Q0.62 Inst Own11.50% Short Float0.23% Perf Quarter-2.33%
Sales39.70B P/S2.57 EPS this Y42.70% Inst Trans4.51% Short Ratio2.35 Perf Half Y8.12%
Book/sh2.07 P/B19.63 EPS next Y3.58% ROA6.60% Target Price44.33 Perf Year-0.64%
Cash/sh2.13 P/C19.11 EPS next 5Y8.90% ROE94.50% 52W Range36.41 - 42.32 Perf YTD6.33%
Dividend1.98 P/FCF27.01 EPS past 5Y-7.40% ROI16.00% 52W High-4.91% Beta0.74
Dividend %4.87% Quick Ratio0.50 Sales past 5Y3.10% Gross Margin68.70% 52W Low10.52% ATR0.48
Employees95490 Current Ratio0.70 Sales Q/Q6.10% Oper. Margin18.20% RSI (14)52.11 Volatility1.27% 0.94%
OptionableYes Debt/Eq7.91 EPS Q/Q50.20% Profit Margin12.50% Rel Volume0.64 Prev Close40.63
ShortableYes LT Debt/Eq5.82 EarningsJul 31 BMO Payout79.40% Avg Volume2.44M Price40.24
Recom2.00 SMA201.20% SMA500.90% SMA2001.04% Volume551,177 Change-0.96%
Jun-17-19Resumed Morgan Stanley Underweight
Mar-08-19Downgrade Shore Capital Buy → Hold
Feb-22-19Downgrade UBS Buy → Neutral
Jan-14-19Downgrade Exane BNP Paribas Outperform → Neutral
Dec-11-18Resumed Jefferies Buy
Oct-09-18Initiated Guggenheim Neutral
Aug-30-18Downgrade Liberum Buy → Hold
Apr-04-18Upgrade Exane BNP Paribas Neutral → Outperform
Mar-22-18Upgrade Morgan Stanley Underweight → Equal-Weight
Feb-09-18Upgrade Kepler Reduce → Hold
Nov-06-17Downgrade Investec Buy → Hold
Oct-26-17Downgrade BofA/Merrill Buy → Neutral
Sep-08-17Downgrade Morgan Stanley Equal-Weight → Underweight
Jul-05-17Downgrade Citigroup Buy → Neutral
May-26-17Upgrade Berenberg Hold → Buy
Apr-05-17Upgrade Exane BNP Paribas Underperform → Neutral
Mar-09-17Initiated Liberum Buy
Mar-09-17Initiated Kepler Reduce
Oct-20-16Initiated Investec Buy
Sep-23-16Initiated Piper Jaffray Overweight
Jun-26-19 06:24AM  Gilead Inks Deal With Carna Biosciences for Immuno-Oncology Zacks
Jun-21-19 09:20AM  Arbutus Gets Clearance to Initiate Hepatitis Study, Stock Up Zacks
Jun-20-19 09:18AM  AstraZeneca's Triple-Combo COPD Inhaler Gets Japan's Nod Zacks
07:40AM  5 Undervalued Stocks to Buy InvestorPlace
06:33AM  Gilead (GILD) Teams Up With Nurix for Cancer and Other Drugs Zacks
04:18AM  GSK offers concessions to address EU concerns over Pfizer deal Reuters
Jun-19-19 01:37PM  GSK kicks off sale of $1.2 billion consumer health drugs: sources Reuters
10:21AM  Merck's Keytruda Gets 2nd Label Expansion Approval in June Zacks
Jun-18-19 10:30AM  Sanofi Partners Google to Build Healthcare Innovation Lab Zacks
08:59AM  AstraZeneca/Merck's Lynparza Wins EU Nod for First-Line Use Zacks
Jun-17-19 11:02AM  GSK pharma head flags need for speed in high-pressure drug market Reuters
10:08AM  Health Care Digest: Not-so-secret target of new UC-GSK alliance, East Bay toolmaker's big round and more American City Business Journals
09:30AM  Pfizer's $11 Billion Cancer-Drug Deal Takes Pricey Path to Growth Bloomberg
06:33AM  UPDATE 2-VBI's shares plunge after hep B vaccine fails secondary goal in late-stage trial Reuters
06:09AM  VBI hepatitis B vaccine meets main goals in late-stage trial Reuters
Jun-14-19 03:42PM  Heres What Hedge Funds Think About GlaxoSmithKline plc (GSK) Insider Monkey
09:00AM  Glaxo Inks Genome Research Deal With University of California Zacks
Jun-13-19 08:36PM  PRESS DIGEST- Financial Times - June 14 Reuters
04:12PM  Amgen, Biogen, Gilead and Novo Nordisk have very high capacity for M&A, says Moodys MarketWatch
08:21AM  GSK links up with US university on genome research Financial Times
Jun-12-19 09:33PM  Edited Transcript of GSK.L earnings conference call or presentation 25-Oct-17 1:00pm GMT Thomson Reuters StreetEvents
Jun-07-19 04:01AM  Germany's Stada buys six of GSK's consumer brands, eyes further deals Reuters
Jun-06-19 05:15PM  Nucala (mepolizumab) Gains FDA Approval for Two New Self-Administration Options Business Wire
08:15AM  Better Buy: GlaxoSmithKline vs. Merck Motley Fool
Jun-05-19 09:09AM  Glaxo's Nucala Gets CHMP Nod for 2 Self-Administered Options Zacks
Jun-04-19 11:52AM  Emergent (EBS) Wins HHS Contract to Supply VIGIV Product Zacks
10:09AM  Trump strikes "supportive" tone in meeting with British business leaders -sources Reuters
Jun-03-19 08:17PM  PRESS DIGEST- British Business - June 4 Reuters
05:30PM  Let's deepen economic ties, Britain's May tells Trump Reuters
08:05AM  Matinas BioPharma to Present at the 9th Annual LD Micro Invitational GlobeNewswire
May-28-19 04:02PM  Gilead Gains 6.8% YTD as HIV Franchise Maintains Momentum Zacks
May-27-19 05:55AM  Glaxo's Shingles Vaccine Shingrix Gets Approval in China Zacks
May-24-19 09:30AM  Pharma Stock Roundup: MRK's Cancer Biotech Buyout, ABBV, LLY's Pipeline Updates Zacks
May-23-19 01:10PM  GSK gets approval for Shingles vaccine in China American City Business Journals
01:09PM  GSK brings back bonuses for some sales reps Reuters
12:59PM  GSK's shingles vaccine approved for use in China in adults aged 50 and above Reuters
10:31AM  GSK to change incentives for sales representatives Reuters
09:00AM  Better Buy: Johnson & Johnson vs. GlaxoSmithKline Motley Fool
03:14AM  GlaxoSmithKline revamps incentives for sales representatives Financial Times
12:00AM  3 Top Stocks With High Dividend Yields Motley Fool
May-21-19 08:46AM  Merck's Keytruda Fails in Late-Stage Breast Cancer Study Zacks
08:13AM  Merck agrees $1bn deal to buy biopharmaceutical company Peloton Financial Times
07:08AM  Edited Transcript of GSK.L earnings conference call or presentation 1-May-19 1:00pm GMT Thomson Reuters StreetEvents
May-20-19 02:44PM  Primary Drivers of the Chinese Economy Investopedia
May-17-19 09:13AM  Thermo Fisher Acquires GlaxoSmithKline's Drug Production Site Zacks
02:14AM  GSK and Novartis liniment marketing misled Australian consumers - court Reuters
May-16-19 11:49AM  How to Invest in Biotech: Known Your Catalysts
05:00AM  Thermo Fisher Scientific to Acquire Manufacturing Site in Cork, Ireland, from GSK PR Newswire
May-15-19 07:00AM  Matinas BioPharma Announces a Research Collaboration with ViiV Healthcare to Evaluate Formulation of Antiviral Drug Candidates GlobeNewswire
May-14-19 02:02AM  Stanford Dad Accused of $6.5 Million Payment in College Scandal Has a New Problem Bloomberg
May-12-19 11:00AM  Top vaccine makers Merck and Pfizer target China and older adults next CNBC
10:02AM  The money behind vaccines CNBC Videos
May-08-19 09:37PM  GSK-Pfizer deal gets approval from Australia's anti-trust watchdog Reuters
09:02PM  Australia's anti-trust watchdog gives go-ahead for GSK-Pfizer consumer healthcare deal Reuters
11:44AM  Theravance (TBPH) Q1 Loss Widens, Revenues Miss Estimates Zacks
09:46AM  Clovis (CLVS) Q1 Earnings Top Estimates, Rubraca Sales Strong Zacks
May-07-19 04:54PM  What's in Store for Axsome (AXSM) This Earnings Season? Zacks
May-06-19 09:21AM  The Zacks Analyst Blog Highlights: Merck, Pfizer, AbbVie, Sanofi and Glaxo Zacks
May-04-19 01:09PM  UK's Vectura wins patent infringement case against GlaxoSmithKline in U.S Reuters
12:24PM  UK's Vectura wins patent infringement case against GlaxoSmithKline in U.S. Reuters
May-03-19 03:41PM  Emergent (EBS) Earnings & Revenues Miss Estimates in Q1 Zacks
10:45AM  Gilead (GILD) Earnings Beat, Revenues Miss Estimates in Q1 Zacks
06:10AM  Pharma Stock Roundup: MRK, LLY, PFE Report Q1 Earnings, SNY, ABBV Drugs Get EU Nod Zacks
02:56AM  UK Stocks-Factors to watch on May 3 Reuters
01:28AM  UK Stocks-Factors to watch on May 3 Reuters
May-02-19 11:51PM  Investors Chronicle: Greene King, Standard Chartered, GlaxoSmithKline Financial Times
01:46PM  GSK's 3-in-1 inhalable drug shows promise in asthma study Reuters
01:20PM  GSK's Trelegy Ellipta meets key goal in late-stage asthma study Reuters
10:00AM  Is GlaxoSmithKline a Buy? Motley Fool
09:16AM  Glaxo (GSK) Beats on Q1 Earnings & Sales, Shingrix Impresses Zacks
May-01-19 05:58PM  GlaxoSmithKline plc (GSK) Q1 2019 Earnings Call Transcript Motley Fool
02:08PM  GSK sees shingles vaccine sales rising, as free cash flow concerns weigh Reuters
01:08PM  GSK sees shingles vaccine sales rising, as free cash flow concerns weigh Reuters
09:34AM  Can Allergan (AGN) Beat Earnings Estimates Again in Q1? Zacks
07:44AM  Glaxo (GSK) Beats Earnings & Revenue Estimates in Q1 Zacks
07:39AM  GSK sales boosted by shingles and HIV treatments success Financial Times
07:29AM  GSK first-quarter beats estimates on shingles vaccine surge Reuters
Apr-30-19 11:05PM  Stocks to watch: Sainsburys, Pearson, Just Eat, GSK Financial Times
09:33AM  Pfizer (PFE) Beats on Q1 Earnings & Sales, Raises EPS View Zacks
08:32AM  What's in Store for ANI Pharmaceuticals (ANIP) Q1 Earnings? Zacks
08:02AM  What's in Store for BioSpecifics (BSTC) This Earnings Season? Zacks
Apr-29-19 04:41PM  Arcus (RCUS) to Report Q1 Earnings: What's in the Cards? Zacks
10:53AM  Zoetis (ZTS) to Report Q1 Earnings: What's in the Cards? Zacks
09:43AM  Teva (TEVA) to Report Q1 Earnings: What's in the Cards? Zacks
Apr-26-19 04:07PM  Will HIV Franchise Sales Drive Gilead's (GILD) Q1 Earnings? Zacks
02:01PM  Is a Beat in Store for Glaxo (GSK) This Earnings Season? Zacks
11:43AM  GSK's HIV drug wins European panel thumbs-up Reuters
Apr-25-19 11:50AM  Can Keytruda Drive Merck's (MRK) Q1 Earnings and Sales? Zacks
10:08AM  Pfizer Stock Has Positive and Negative Catalysts Going Into Results InvestorPlace
09:42AM  Exelixis (EXEL) to Report Q1 Earnings: What's in Store? Zacks
Apr-24-19 09:03PM  Top 5 Dividend Stocks in the FTSE for 2018 Investopedia
04:45PM  Lannett (LCI) to Report Q3 Earnings: What's in the Cards? Zacks
04:25PM  Eli Lilly (LLY) to Report Q1 Earnings: What's in the Cards? Zacks
01:55PM  Drug maker to spend $100M expanding Montana facility Associated Press
10:02AM  Novartis (NVS) Q1 Earnings Beat Estimates, Revenues Up Y/Y Zacks
03:27AM  Malawi starts pilot of malaria vaccine for children Financial Times
Apr-23-19 09:46AM  Alexion (ALXN) to Report Q1 Earnings: What's in the Cards? Zacks
09:27AM  What's in Store for Celgene Corporation (CELG) Q1 Earnings? Zacks
09:10AM  Are Investors Undervaluing GlaxoSmithKline (GSK) Right Now? Zacks
08:44AM  2 Best Biotech Buyout Plays Motley Fool
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories primarily under the Sensodyne, parodontax, Poligrip, Voltaren, Panadol, Otrivin, and Theraflu brand names. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, pods, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, and malted drinks and foods. Its primary collaboration is with 23andMe; and strategic alliance is with Merck KGaA to jointly develop and commercialize M7824. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLCDirectorMay 28Buy14.00385,7145,399,9961,915,275May 30 05:47 PM
GLAXOSMITHKLINE PLCDirectorApr 22Buy18.00325,0005,850,0001,992,550Apr 24 07:28 PM
GLAXOSMITHKLINE PLCFormer 10% holderJul 30Buy11.00148,8181,636,998624,422Aug 01 06:32 PM
GLAXOSMITHKLINE PLC10% OwnerJul 17Buy12.5080,0001,000,0001,934,006Jul 17 05:01 PM
GLAXOSMITHKLINE PLC10% OwnerJul 02Buy13.00269,2303,499,9903,697,912Jul 03 05:59 PM